BRIEF published on 09/09/2026 at 07:35, 3 days 21 hours ago GENFIT Explores Long-Term Prospects for MASH Diagnostic Technology U.S. Market GENFIT Commercial Opportunity MASH Diagnostics NISTM Technology
BRIEF published on 09/09/2026 at 07:35, 3 days 21 hours ago GENFIT explore les perspectives à long terme de la technologie de diagnostic MASH Marché Américain GENFIT Diagnostics MASH Technologie NISTM Opportunité Commerciale
BRIEF published on 09/09/2026 at 07:15, 3 days 22 hours ago Antin Infrastructure Partners Releases Half-Year 2026 Financial Report Investment Strategies Global Operations Half-year Financial Report AMF Filing Antin Infrastructure
BRIEF published on 09/09/2026 at 07:15, 3 days 22 hours ago Antin Infrastructure Partners publie son rapport financier semestriel 2026 Stratégies D'investissement Rapport Financier Semestriel Opérations Mondiales Dépôt AMF Infrastructure Antin
BRIEF published on 09/09/2026 at 07:10, 3 days 22 hours ago TerraPay Partners with Alipay+ to Enhance Global Payment Interoperability Cross-border Payments Global Commerce Digital Wallets TerraPay Alipay+
BRIEF published on 09/09/2026 at 07:10, 3 days 22 hours ago TerraPay s'associe à Alipay+ pour améliorer l'interopérabilité des paiements internationaux Paiements Transfrontaliers Commerce Mondial Portefeuilles Numériques TerraPay Alipay+
BRIEF published on 09/09/2026 at 07:05, 3 days 22 hours ago DocMorris AG Issues CHF 100 Million Convertible Bonds Private Placement Convertible Bonds Sustainable Growth Maturity Extension DocMorris AG
BRIEF published on 09/09/2026 at 07:05, 3 days 22 hours ago DocMorris AG émet des obligations convertibles d'une valeur de 100 millions de francs suisses. Obligations Convertibles Croissance Durable Placement Privé Extension De Maturité DocMorris AG
BRIEF published on 09/09/2026 at 07:05, 3 days 22 hours ago BioVersys Announces Half-Year 2026 Results Pharmaceutical Industry Clinical Trials R&D Expenses BioVersys AG 2026 Financial Results
BRIEF published on 09/09/2026 at 07:05, 3 days 22 hours ago BioVersys annonce ses résultats du premier semestre 2026 Essais Cliniques Industrie Pharmaceutique Dépenses De R&D BioVersys AG Résultats Financiers 2026
Published on 09/12/2026 at 02:35, 1 day 2 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 6 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 7 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 12 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 11 hours 24 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 21 hours 44 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 7 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 7 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 9 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 22 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 22 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 9 hours ago Availability of the 2026 Interim Financial Report
